These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 1848666

  • 1. Requirement of phosphatidylinositol-3 kinase modification for its association with p60src.
    Fukui Y, Hanafusa H.
    Mol Cell Biol; 1991 Apr; 11(4):1972-9. PubMed ID: 1848666
    [Abstract] [Full Text] [Related]

  • 2. Phosphatidylinositol-3 kinase is activated in v-src, v-yes, and v-fps transformed chicken embryo fibroblasts.
    Fukui Y, Saltiel AR, Hanafusa H.
    Oncogene; 1991 Mar; 6(3):407-11. PubMed ID: 1849246
    [Abstract] [Full Text] [Related]

  • 3. Phosphatidylinositol kinase activity associates with viral p60src protein.
    Fukui Y, Hanafusa H.
    Mol Cell Biol; 1989 Apr; 9(4):1651-8. PubMed ID: 2542773
    [Abstract] [Full Text] [Related]

  • 4. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
    Hamaguchi M, Xiao H, Uehara Y, Ohnishi Y, Nagai Y.
    Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
    [Abstract] [Full Text] [Related]

  • 5. The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.
    Liu X, Marengere LE, Koch CA, Pawson T.
    Mol Cell Biol; 1993 Sep; 13(9):5225-32. PubMed ID: 7689147
    [Abstract] [Full Text] [Related]

  • 6. Deletions in the SH2 domain of p60v-src prevent association with the detergent-insoluble cellular matrix.
    Fukui Y, O'Brien MC, Hanafusa H.
    Mol Cell Biol; 1991 Mar; 11(3):1207-13. PubMed ID: 1705002
    [Abstract] [Full Text] [Related]

  • 7. The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells.
    Han JW, Gaut J, Burstein E, Sadowski H, Young D, Macara IG.
    Oncogene; 1990 Apr; 5(4):467-74. PubMed ID: 2158036
    [Abstract] [Full Text] [Related]

  • 8. Evidence for autoinhibitory regulation of the c-src gene product. A possible interaction between the src homology 2 domain and autophosphorylation site.
    Fukami Y, Sato K, Ikeda K, Kamisango K, Koizumi K, Matsuno T.
    J Biol Chem; 1993 Jan 15; 268(2):1132-40. PubMed ID: 7678249
    [Abstract] [Full Text] [Related]

  • 9. Cooperation of Src homology domains in the regulated binding of phosphatidylinositol 3-kinase. A role for the Src homology 2 domain.
    Haefner B, Baxter R, Fincham VJ, Downes CP, Frame MC.
    J Biol Chem; 1995 Apr 07; 270(14):7937-43. PubMed ID: 7713890
    [Abstract] [Full Text] [Related]

  • 10. Mutations in the SH3 domain of the src oncogene which decrease association of phosphatidylinositol 3'-kinase activity with pp60v-src and alter cellular morphology.
    Wages DS, Keefer J, Rall TB, Weber MJ.
    J Virol; 1992 Apr 07; 66(4):1866-74. PubMed ID: 1312609
    [Abstract] [Full Text] [Related]

  • 11. A glycoprotein in the plasma membrane matrix as a major potential substrate of p60v-src.
    Hamaguchi M, Matsuda M, Hanafusa H.
    Mol Cell Biol; 1990 Feb 07; 10(2):830-6. PubMed ID: 2153925
    [Abstract] [Full Text] [Related]

  • 12. Multiple SH2-mediated interactions in v-src-transformed cells.
    Koch CA, Moran MF, Anderson D, Liu XQ, Mbamalu G, Pawson T.
    Mol Cell Biol; 1992 Mar 07; 12(3):1366-74. PubMed ID: 1545818
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol.
    Kwon HJ, Yoshida M, Fukui Y, Horinouchi S, Beppu T.
    Cancer Res; 1992 Dec 15; 52(24):6926-30. PubMed ID: 1458481
    [Abstract] [Full Text] [Related]

  • 16. Different properties of monomer and heterodimer forms of phosphatidylinositol 3-kinases.
    Shibasaki F, Fukui Y, Takenawa T.
    Biochem J; 1993 Jan 01; 289 ( Pt 1)(Pt 1):227-31. PubMed ID: 8380984
    [Abstract] [Full Text] [Related]

  • 17. Activation of the proto-oncogene p60c-src by point mutations in the SH2 domain.
    O'Brien MC, Fukui Y, Hanafusa H.
    Mol Cell Biol; 1990 Jun 01; 10(6):2855-62. PubMed ID: 2111444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of type I phosphatidylinositol kinase activity with mutationally activated forms of human pp60c-src.
    Chan TO, Tanaka A, Bjorge JD, Fujita DJ.
    Mol Cell Biol; 1990 Jun 01; 10(6):3280-3. PubMed ID: 2160600
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.